NuCana (NCNA) Total Liabilities (2016 - 2025)
NuCana's (NCNA) quarterly Total Liabilities came in at $7.3 million in Q4 2025, down 35.29% year-on-year from $11.3 million in Q4 2024, and down 15.03% quarter-over-quarter from $8.6 million in Q3 2025.
NuCana (NCNA) Total Liabilities (2016 - 2025) Analysis & Trends
NuCana has disclosed Total Liabilities across 10 years of filings, most recently posting $7.3 million for Q4 2025.
- Total Liabilities for Q4 2025 came in at $7.3 million, down 35.29% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.3 million (down 35.29% YoY), and the FY2025 annual result was $7.3 million, down 35.6% from the prior year.
- Total Liabilities came in at $7.3 million for Q4 2025 at NuCana, down from $8.6 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $23.2 million in Q4 2022 to a low of $7.3 million in Q4 2025.
- The 5-year median for Total Liabilities is $16.1 million (2021), against an average of $15.3 million.
- Across the five-year window, Total Liabilities soared 54.26% in 2021 and plunged 56.31% in 2025, its largest moves.
- NuCana's Total Liabilities stood at $16.1 million in 2021, then soared by 44.11% to $23.2 million in 2022, then slumped by 30.76% to $16.0 million in 2023, then retreated by 29.43% to $11.3 million in 2024, then tumbled by 35.29% to $7.3 million in 2025.
- The last three Total Liabilities figures came in at $7.3 million (Q4 2025), $8.6 million (Q3 2025), and $11.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 19.51 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 10.44 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 137.56 Mn |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - | 7.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.33 Mn |
| Sep 30, 2025 | 8.62 Mn |
| Jun 30, 2025 | 11.78 Mn |
| Mar 31, 2025 | 9.35 Mn |
| Dec 31, 2024 | 11.32 Mn |
| Sep 30, 2024 | 19.73 Mn |
| Jun 30, 2024 | 20.54 Mn |
| Mar 31, 2024 | 18.61 Mn |
| Dec 31, 2023 | 16.04 Mn |
| Sep 30, 2023 | 15.44 Mn |
| Jun 30, 2023 | 17.36 Mn |
| Mar 31, 2023 | 20.66 Mn |
| Dec 31, 2022 | 23.17 Mn |
| Sep 30, 2022 | 18.81 Mn |
| Jun 30, 2022 | 13.34 Mn |
| Mar 31, 2022 | 17.05 Mn |
| Dec 31, 2021 | 16.08 Mn |
| Sep 30, 2021 | 17.01 Mn |
| Jun 30, 2021 | 11.37 Mn |
| Mar 31, 2021 | 12.98 Mn |